Global Fondaparinux Market Size & Outlook, 2025-2030

The global fondaparinux market size was estimated at USD 688.0 million in 2024 and is projected to reach USD 990.9 million by 2030, growing at a CAGR of 6.3% from 2025 to 2030.
Revenue, 2024 (US$M)
$688.0
Forecast, 2030 (US$M)
$990.9
CAGR, 2025 - 2030
6.3%
Report Coverage
Worldwide

Global fondaparinux market highlights

  • The global fondaparinux market generated a revenue of USD 688.0 million in 2024 and is expected to reach USD 990.9 million by 2030.
  • The market is expected to grow at a CAGR (2025 - 2030) of 6.3% by 2030.
  • In terms of segment, deep vein thrombosis accounted for a revenue of USD 433.9 million in 2024.
  • Pulmonary Embolism is the most lucrative type segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2024.
  • Country-wise, UK is expected to register the highest CAGR from 2025 to 2030.

Global data book summary

Market revenue in 2024USD 688.0 million
Market revenue in 2030USD 990.9 million
Growth rate6.3% (CAGR from 2025 to 2030)
Largest segmentDeep vein thrombosis
Fastest growing segmentPulmonary Embolism
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDeep Vein Thrombosis, Pulmonary Embolism

Other key industry trends

  • In terms of revenue, the North America accounted for 37.6% of the global fondaparinux market in 2024.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, UK is the fastest growing regional market and is projected to reach USD 65.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Fondaparinux Market Companies

Name Profile # Employees HQ Website
Kaifeng View profile 501-1000 Hangzhou, Zhejiang, China, Asia https://www.nb-kaifeng.com
Wismed View profile - Beijing, Beijing, China, Asia https://www.wismed.com.cn
ScinoPharm Taiwan View profile 501-1000 Tainan, T'ai-wan, Taiwan, Asia http://www.scinopharm.com/
Alchemia View profile 1-10 Eight Mile Plains, Queensland, Australia, Oceania http://www.alchemia.com.au/
Lupin Pharmaceuticals View profile 501-1000 Baltimore, Maryland, United States, North America http://www.lupinpharmaceuticals.com
Bayer HealthCare View profile 10001+ Leverkusen, Nordrhein-Westfalen, Germany, Europe http://www.bayerhealthcare.com
Apotex Inc. View profile 10001+ Toronto, Ontario, Canada, North America http://www.apotex.com
Mylan View profile 10001+ https://www.mylan.in/
GlaxoSmithKline View profile 10001+ London, England, United Kingdom, Europe http://www.gsk.com
Boehringer Ingelheim View profile 10001+ Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe https://www.boehringer-ingelheim.com/
GSK PLC ADR View profile 70200 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS https://www.gsk.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com
Dr Reddy's Laboratories Ltd ADR View profile 22822 8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, India, 500 034 https://www.drreddys.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com

Global fondaparinux market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fondaparinux market will help companies and investors design strategic landscapes.


Deep vein thrombosis was the largest segment with a revenue share of 63.07% in 2024. Horizon Databook has segmented the Global fondaparinux market based on deep vein thrombosis, pulmonary embolism covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Fondaparinux Type Outlook (Revenue, USD Million, 2018-2030)
    • Deep Vein Thrombosis
    • Pulmonary Embolism
  • Global Fondaparinux Product Outlook (Revenue, USD Million, 2018-2030)
    • Branded
    • Generic
  • Global Fondaparinux Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Other Pharmacies

Reasons to subscribe to Global fondaparinux market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global fondaparinux market databook

  • Our clientele includes a mix of fondaparinux market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global fondaparinux market , including forecasts for subscribers. This global databook contains high-level insights into Global fondaparinux market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global fondaparinux market size, by regions, 2018-2030 (US$M)

Top 10 countries: Fondaparinux market size, 2024 (US$M)

Global fondaparinux market share, by type, 2024 & 2030 (%, US$M)

Fondaparinux market: Opportunity assessment by country

Global fondaparinux market, by region, 2024 (US$M)

Global fondaparinux market size, by regions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online